Venous Thromboembolic Disease Clinical Trial
Official title:
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin at a Fixed Curative Dose of 4000 IU Twice a Day Versus at Dose / Weight Twice a Day as Part of the Treatment of Venous Thromboembolic Disease
Elderly subjects are at greater risk of thrombophlebitis than the general population, but also of bleeding when anticoagulant therapy is initiated. Enoxaparin is one of the most widely used anticoagulants in the management of venous thromboembolism in the world. Its use is not codified in the elderly, because too few studies have been carried out in people over 75 years old. For several years, Enoxaparin in curative treatment has been administered at a reduced dosage of 4000 IU twice a day (and not at a standard dose of 100 IU / kg) at the Geriatrics center of the CRHU in Strasbourg with the clinical impression of a reduction the risk of serious bleeding without reduction in therapeutic efficacy in this very elderly population. Confirmation of a reduction in the risk of bleeding at this dosage could be the start of a change in prescribing practices, towards a more suitable dosage in the elderly.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04414332 -
Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
|
||
| Recruiting |
NCT03206372 -
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
|
||
| Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
| Not yet recruiting |
NCT02188056 -
Observational Prospectif Monocentric Registry of Patients Suffering From VIE
|
N/A | |
| Completed |
NCT04846725 -
Predictors of Attempted Inferior Vena Cava Filters Retrieval.
|
||
| Completed |
NCT01729559 -
Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
|
Phase 4 | |
| Completed |
NCT01466426 -
The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)
|
N/A | |
| Active, not recruiting |
NCT05396157 -
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
|
||
| Active, not recruiting |
NCT00691470 -
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
|
Phase 2/Phase 3 | |
| Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
| Recruiting |
NCT03887806 -
Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
|
||
| Not yet recruiting |
NCT06232551 -
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
|
N/A | |
| Recruiting |
NCT05993533 -
Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
|
||
| Not yet recruiting |
NCT05515549 -
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
|
||
| Recruiting |
NCT04211181 -
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
|
N/A | |
| Completed |
NCT04818151 -
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
|
||
| Recruiting |
NCT05089227 -
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
|
Phase 2 | |
| Completed |
NCT03894878 -
Association Between Genetic Variant Scores and Warfarin Effect
|
||
| Completed |
NCT00556426 -
Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.
|
N/A | |
| Not yet recruiting |
NCT04158973 -
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
|
N/A |